Acute Heart Failure (AHF), Cardiogenic Shock
Conditions
Brief summary
The goal of this observational study is to learn whether information collected during routine hospital care, together with blood and urine samples, can help doctors better identify different types of cardiogenic shock and better predict outcomes in adults hospitalized with acute heart failure and cardiogenic shock. The main question is whether clinical findings, imaging results, and biomarkers, including sex-specific factors, are associated with the risk of death within 30 days. Participants will not receive an experimental treatment. Researchers will collect data from routine care, collect additional blood and urine samples for biobanking, and follow participants after hospital discharge
Interventions
None listed
Sponsors
University Heart Center Freiburg - Bad Krozingen
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients hospitalized with acute heart failure SCAI stage B - E.
Exclusion criteria
* Not capable of providing informed consent due to reasons not attributable to cardiogenic shock * Cardiogenic shock following cardiothoracic surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality | 30 days |
Secondary
| Measure | Time frame |
|---|---|
| Mortality | 6 and 12 months |
| Rehospitalization for heart failure | From hospital discharge until 12 months |
| Rehospitalization for cardiac reasons (non-elective) | From hospital discharge until 12 months |
Countries
Germany
Contacts
CONTACTLucas Bacmeister, MD
Outcome results
None listed